Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 3Phase 1 2Phase 4 1Phase 2/3 1

Status

Active not recruiting 3Recruiting 1Completed 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 4Tumor-Agnostic 1

Conditions

Breast Neoplasms 70Neoplasms 7Neoplasm Metastasis 5Advanced Breast Cancer 5Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Neoplasms by Site 2Breast Neoplasms, Male 2Breast Diseases 2Skin Diseases 1Recurrence 1Quality of Life 1Low Grade Serous Ovarian Cancer 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Camurati-Engelmann Syndrome 1Breast Neoplasm Female 1Breast Cancer Metastatic 1Breast Cancer Female 1Bone Density 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Metastatic Breast Cancer 1

Interventions

Leucovorin 22Fluorouracil 22Paclitaxel 21Gemcitabine 21Docetaxel 21Capecitabine 21Irinotecan 16Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × Anastrozole × Clear all
NCT07174336 2026-06-04

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Eli Lilly and Company

Phase 3 Recruiting
920 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04964934 2026-04-21

SERENA-6

AstraZeneca

Phase 3 Active not recruiting
315 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

NCT01602380 2026-02-27

FALCON

AstraZeneca

Phase 3 Completed
462 enrolled 20 charts
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04711252 2025-10-14

SERENA-4

AstraZeneca

Phase 3 Active not recruiting
1,370 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

NCT04158362 2025-09-22

AMBRE

UNICANCER

Phase 3 Active not recruiting
180 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡